ArticleCancer science2026

Phase II Trial of Nivolumab in Advanced Solid Tumors Based on Genomic Profiling: BELIEVE Trial (NCCH1901) Subcohort.

Masashi Kanai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.